Annual Current Liabilities
$54.94 M
-$3.34 M-5.73%
December 31, 2024
Summary
- As of March 7, 2025, IBRX annual total current liabilities is $54.94 million, with the most recent change of -$3.34 million (-5.73%) on December 31, 2024.
- During the last 3 years, IBRX annual current liabilities has fallen by -$314.05 million (-85.11%).
- IBRX annual current liabilities is now -89.03% below its all-time high of $500.86 million, reached on December 31, 2022.
Performance
IBRX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$54.94 M
-$6.02 M-9.87%
December 31, 2024
Summary
- As of March 7, 2025, IBRX quarterly total current liabilities is $54.94 million, with the most recent change of -$6.02 million (-9.87%) on December 31, 2024.
- Over the past year, IBRX quarterly current liabilities has dropped by -$6.02 million (-9.87%).
- IBRX quarterly current liabilities is now -91.04% below its all-time high of $613.48 million, reached on June 30, 2023.
Performance
IBRX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
IBRX Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.7% | -9.9% |
| 3 y3 years | -85.1% | -9.9% |
| 5 y5 years | - | -9.9% |
IBRX Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -89.0% | at low | -91.0% | +2.2% |
| 5 y | 5-year | -89.0% | at low | -91.0% | +2.2% |
| alltime | all time | -89.0% | at low | -91.0% | +2.2% |
ImmunityBio Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $54.94 M(-5.7%) | $54.94 M(-9.9%) |
| Sep 2024 | - | $60.96 M(-1.9%) |
| Jun 2024 | - | $62.11 M(+15.5%) |
| Mar 2024 | - | $53.76 M(-7.8%) |
| Dec 2023 | $58.28 M(-88.4%) | $58.28 M(-35.5%) |
| Sep 2023 | - | $90.32 M(-85.3%) |
| Jun 2023 | - | $613.48 M(+8.6%) |
| Mar 2023 | - | $564.95 M(+12.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $500.86 M(+35.7%) | $500.86 M(+607.0%) |
| Sep 2022 | - | $70.84 M(-81.2%) |
| Jun 2022 | - | $376.05 M(-1.3%) |
| Mar 2022 | - | $381.01 M(+3.3%) |
| Dec 2021 | $369.00 M(+441.6%) | $369.00 M(+464.1%) |
| Sep 2021 | - | $65.41 M(-12.1%) |
| Jun 2021 | - | $74.43 M(-6.8%) |
| Mar 2021 | - | $79.86 M(+17.2%) |
| Dec 2020 | $68.13 M | $68.13 M |
FAQ
- What is ImmunityBio annual total current liabilities?
- What is the all time high annual current liabilities for ImmunityBio?
- What is ImmunityBio annual current liabilities year-on-year change?
- What is ImmunityBio quarterly total current liabilities?
- What is the all time high quarterly current liabilities for ImmunityBio?
- What is ImmunityBio quarterly current liabilities year-on-year change?
What is ImmunityBio annual total current liabilities?
The current annual current liabilities of IBRX is $54.94 M
What is the all time high annual current liabilities for ImmunityBio?
ImmunityBio all-time high annual total current liabilities is $500.86 M
What is ImmunityBio annual current liabilities year-on-year change?
Over the past year, IBRX annual total current liabilities has changed by -$3.34 M (-5.73%)
What is ImmunityBio quarterly total current liabilities?
The current quarterly current liabilities of IBRX is $54.94 M
What is the all time high quarterly current liabilities for ImmunityBio?
ImmunityBio all-time high quarterly total current liabilities is $613.48 M
What is ImmunityBio quarterly current liabilities year-on-year change?
Over the past year, IBRX quarterly total current liabilities has changed by -$6.02 M (-9.87%)